37% of New Drugs Approved by FDA in 2014 were for Treatment of Rare Diseases | Pharmaguy's Insights Into Drug Industry News | Scoop.it

New data from the FDA (here) shows that 2014 was a banner year for orphan drugs, which are drugs that treat "rare" diseases/disorders affecting fewer than 200,000 people in the U.S.


Orphan drug approvals represent 37% of all new drug approvals in 2014. Today, orphan drugs have the potential to turn into blockbusters with annual sales over $1 Billion.


Read more here.